Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV003368198 | SCV004056929 | uncertain significance | Hereditary cancer-predisposing syndrome | 2023-07-06 | criteria provided, single submitter | clinical testing | The c.760_761delAAinsGC variant (also known as p.K254A), located in coding exon 5 of the NTHL1 gene, results from an in-frame deletion of AA and insertion of GC at nucleotide positions 760 to 761. This results in the substitution of the lysine residue for a alanine residue at codon 254, an amino acid with dissimilar properties. This amino acid position is not well conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive (Choi Y et al. PLoS ONE. 2012; 7(10):e46688). Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |